tm logo

Monitor this mark

View On USPTO

ENABLE THE MOLECULE
Live/Registered
REGISTERED

on 06 Aug 2024

Last Applicant/ Owned by

WuXi Biologics Ireland Limited

Mullagharlin, Dundalk

Co Louth

IE

A91X56F

Serial Number

97432013 filed on 27th May 2022

Registration Number

7469449 registered on 06th Aug 2024

in the Principal Register

Correspondent Address

Mark Tidwell

Mark Tidwell HAYNES AND BOONE, LLP

2323 VICTORY AVENUE, SUITE 700

DALLAS, TX 75219

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ENABLE THE MOLECULE

Developing products for others; developing medicine services; scientific research and development; medicine research; research and development of new products; technical consulting services in the field of technology development of biologics; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibo Read More

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Developing products for others; developing medicine services; scientific research and development; medicine research; research and development of new products; technical consulting services in the field of technology development of biologics; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies; Scientific laboratory services, namely, providing shared wet laboratory facilities and shared laboratory apparatus and instruments for others

First Use Date in General

30th Apr 2022

First Use Date in Commerce

30th Apr 2022

Class [035]
Advertising, Business & Retail Services

Incubation services, namely, providing work space and access to work space containing business equipment and lab equipment to emerging and start-up companies; business incubator services, namely, facilitating innovation and collaborative interactions between universities, research institutions, technology start-ups, and the business community; business advisory and business strategic planning services, namely, providing consulting and business information; business development services, namely, providing start-up support for businesses of others

First Use Date in General

30th Apr 2022

First Use Date in Commerce

30th Apr 2022

Class [040]
Treatment & Processing of Materials Services

Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals; Custom manufacture of nutraceuticals; Custom manufacture of vitamins for humans

First Use Date in General

30th Apr 2022

First Use Date in Commerce

30th Apr 2022

Specimens

ENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimenENABLE THE MOLECULE specimen

Mark Details

Serial Number

No 97432013

Mark Type

No Service Mark

Attorney Docket Number

No 55140.35US01

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
06th Aug 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
06th Aug 2024REGISTERED-PRINCIPAL REGISTER
02th Jul 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02th Jul 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06th Mar 2024STATEMENT OF USE PROCESSING COMPLETE
06th Mar 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
14th Feb 2024TEAS STATEMENT OF USE RECEIVED
14th Feb 2024USE AMENDMENT FILED
07th Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th Feb 2024SOU EXTENSION 1 GRANTED